Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -4.76 is 39% above its 5-year average of -7.78, near the high end of its 5-year range (-32.15–-2.02).
72.89% above its 12-month average of -17.55.
Reported quarterly EPS; no daily interpolation. Q4 FY2026 (2026-06-30): -1.11.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T18:18:33.428Z. Historical observations retain their original dates. Historical series through 2026-02-17.
EARNINGS PER SHARE (EPS)
-4.76
EARNINGS PER SHARE (EPS) AVG TTM
-17.55
EARNINGS PER SHARE (EPS) AVG 3Y
-9.83
EARNINGS PER SHARE (EPS) AVG 5Y
-7.78
EARNINGS PER SHARE (EPS) AVG 10Y
-4.70
EARNINGS PER SHARE (EPS) AVG 15Y
-3.01
EARNINGS PER SHARE (EPS) AVG 20Y
-4.62
CURRENT VS TTM AVG
+72.89%
CURRENT VS 3Y AVG
+51.60%
CURRENT VS 5Y AVG
+38.82%
CURRENT VS 10Y AVG
-1.28%
CURRENT VS 15Y AVG
-58.18%
CURRENT VS 20Y AVG
-3.02%
Palatin Technologies, Inc.
Market Cap
$16.73M
Earnings Per Share (EPS)
-4.76
TTM Avg
-17.55
3Y Avg
-9.83
5Y Avg
-7.78
Market Cap
$16.70M
Earnings Per Share (EPS)
-3.73
TTM Avg
-46.49
3Y Avg
-194.14
5Y Avg
-195.03
Market Cap
$16.76M
Earnings Per Share (EPS)
-0.48
TTM Avg
-0.99
3Y Avg
-1.87
5Y Avg
-3.18
Market Cap
$16.59M
Earnings Per Share (EPS)
-0.91
TTM Avg
-1.07
3Y Avg
-1.56
5Y Avg
-1.55
Market Cap
$16.55M
Earnings Per Share (EPS)
-0.21
TTM Avg
-0.22
3Y Avg
-0.25
5Y Avg
-0.30
Market Cap
$17.11M
Earnings Per Share (EPS)
-1.87
TTM Avg
-0.88
3Y Avg
-1.76
5Y Avg
-2.28
Market Cap
$17.57M
Earnings Per Share (EPS)
-0.66
TTM Avg
-0.90
3Y Avg
-9.28
5Y Avg
-9.88
Market Cap
$15.85M
Earnings Per Share (EPS)
-0.76
TTM Avg
-2.06
3Y Avg
-5.59
5Y Avg
-9.29
Market Cap
$17.74M
Earnings Per Share (EPS)
-16.36
TTM Avg
46.76
3Y Avg
-158.09
5Y Avg
-209.03
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Palatin Technologies, Inc. (PTN) | $16.73M | -4.76 | -17.55 | -9.83 | -7.78 |
| Bionano Genomics, Inc. (BNGO)vs › | $16.70M | -3.73 | -46.49 | -194.14 | -195.03 |
| Marker Therapeutics, Inc. (MRKR)vs › | $16.76M | -0.48 | -0.99 | -1.87 | -3.18 |
| TScan Therapeutics, Inc. (TCRX)vs › | $16.59M | -0.91 | -1.07 | -1.56 | -1.55 |
| Dyadic International, Inc. (DYAI)vs › | $16.55M | -0.21 | -0.22 | -0.25 | -0.30 |
| Lipocine Inc. (LPCN)vs › | $17.11M | -1.87 | -0.88 | -1.76 | -2.28 |
| Cosmos Health Inc. (COSM)vs › | $17.57M | -0.66 | -0.90 | -9.28 | -9.88 |
| BioCardia, Inc. (BCDA)vs › | $15.85M | -0.76 | -2.06 | -5.59 | -9.29 |
| PAVmed Inc. (PAVM)vs › | $17.74M | -16.36 | 46.76 | -158.09 | -209.03 |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.65M | -0.78 | -8.29 | -9461.74 | -302593.36 |
Trailing EPS (TTM)
$-4.76
Forward EPS (Est.)
$-2.18
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2026-06-30 | -2.96 |
| 2025-06-30 | -32.15 |
| 2024-06-30 | -2.02 |
| 2023-06-30 | -2.21 |
| 2022-06-30 | -3.79 |
| 2021-06-30 | -3.55 |
| 2020-06-30 | -2.38 |
| 2019-06-30 | 4.31 |
| 2018-06-30 | 3.12 |
| 2017-06-30 | -1.81 |
| 2016-06-30 | -8.26 |
| 2015-06-30 | -3.65 |
| 2014-06-30 | -3.26 |
| 2013-06-30 | -5.34 |
| 2012-06-30 | -12.36 |
| 2011-06-30 | -15.95 |
| 2010-06-30 | -4.54 |
| 2009-06-30 | -13.90 |
| 2008-06-30 | -42.20 |
| 2007-06-30 | -91.04 |
| 2006-06-30 | -119.95 |
| 2005-06-30 | -66.64 |
| 2004-06-30 | -137.97 |
| 2003-06-30 | -181.27 |
| 2002-06-30 | -284.23 |
| 2001-06-30 | -261.55 |
| 2000-06-30 | -274.94 |
| 1999-06-30 | -505.37 |
| 1998-06-30 | -770.91 |
| 1997-06-30 | -453.15 |
